Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Peroxisome proliferator-activated receptor-alpha-Retinoid X receptor (PPARα-RXR) heterodimer complex is a critical nuclear receptor assembly that governs the transcriptional regulation of lipid and glucose metabolism. Primarily localized in metabolically active tissues such as the liver, heart, and skeletal muscle, the complex is activated by endogenous fatty acids and synthetic ligands like fibrates. Upon activation, the heterodimer binds to specific DNA response elements to enhance the expression of genes responsible for fatty acid uptake and mitochondrial beta-oxidation, while simultaneously modulating lipoprotein metabolism by reducing the synthesis of Apolipoprotein C-III. This dual action effectively lowers circulating triglyceride levels and elevates high-density lipoprotein (HDL) cholesterol, making it a primary therapeutic target for managing atherogenic dyslipidemia and reducing cardiovascular risk. Furthermore, the PPARα-RXR complex exhibits anti-inflammatory properties by antagonizing pro-inflammatory signaling pathways, offering potential benefits in treating metabolic-associated fatty liver disease and other chronic inflammatory conditions (Source: UniProt P23204, StatPearls, PubMed).
The complex acts as a ligand-activated transcription factor. Agonist binding to the PPARα subunit induces a conformational change that allows the PPARα-RXR heterodimer to bind to peroxisome proliferator response elements (PPREs) in the promoter regions of target genes. This recruitment of coactivators leads to the upregulation of genes involved in fatty acid transport and oxidation (e.g., CPT1, ACOX1) and the downregulation of genes like APOC3, thereby lowering plasma triglycerides and increasing HDL cholesterol levels (Source: StatPearls, PubMed).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisome proliferator-activated receptor-alpha-Retinoid X receptor heterodimer complex (PPARα-RXR) (PPARα-RXR).